Research Spotlight: Comparison of Single-Cell Profiling Methods Reveals Strengths and Limitations

The findings will help researchers more efficiently approach projects employing single cell RNA analysis on human biopsy samples.

Call for Nominations: 2025 Sean M. Healey International Prize for Innovation in ALS

The annual Sean M. Healey International Prize for Innovation in ALS is a global prize celebrating excellence in research for a team of investigators who catalyse exceptional discoveries leading to a transformative advance in therapy development in ALS.

Call for Nominations: 2025 Drs. Ayeez and Shelena Lalji & Family Award for Innovative Healing

The Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing is a global award celebrating excellence in research for an individual or team of investigators who are making transformative breakthroughs in the science of repair and regeneration of neurological function.

Request for Nominations: Gupta Family Endowed Award for Innovation in ALS Care

The Gupta Family Endowed Award for Innovation in ALS Care is an annual global award to honor groundbreaking new approaches that lead to exceptional care for individuals living with amyotrophic lateral sclerosis (ALS).

Understanding the Role of Biological Sex in Age-Related Neurological Diseases

Researchers investigate the role of sex differences in age-related neurological diseases.

Research Spotlight: Simulation Model Shows Potential Affordability of Preventative HIV Therapy for Infants

Despite efforts to improve early maternal HIV diagnosis and increase accessibility of antiretroviral therapy to reduce the risk of transmission from 30% to less than 5%, about 130,000 children acquired HIV globally in 2023.

Researchers Identify Link to Kidney in Myotonic Dystrophy Type 1

Thurman M. Wheeler, MD, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in Nature Communications, “Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1.”

Healey & AMG Center for ALS Launches ALS MyMatch: an Early Phase Biomarker Driven Trial Program

Healey & AMG Center for ALS Launches ALS MyMatch: an Early Phase Biomarker Driven Trial Program

From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen

From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen. From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen. We are excited to be expanding our network of ALS researchers and the impactful work being done across our

Research Spotlight: Projecting the Impact of Funding Cuts to the President’s Emergency Plan for AIDS Relief (PEPFAR)

Researchers found that eliminating PEPFAR would lead to 601,000 HIV-related deaths, 565,000 new HIV infections, and would increase population-level healthcare expenditure by $1.7 billion.